T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.92% |
| 2 | Healthcare | 17.37% |
| 3 | Financials | 13.84% |
| 4 | Consumer Discretionary | 13.63% |
| 5 | Industrials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSOD
1426
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $3.91M | ﹤0.01% |
67,468
+3,665
| +6% | +$198K |
|
1427
Sun Communities
SUI
$14.4B
| $3.87M | ﹤0.01% |
30,206
+2,184
| +8% | +$271K |
|
|
AKRO
1428
DELISTED
Akero Therapeutics
AKRO
| $3.86M | ﹤0.01% |
+201,500
| New | +$3.82M |
|
1429
EverQuote
EVER
$867M
| $3.81M | ﹤0.01% |
293,418
+5,160
| +2% | +$53.7K |
|
1430
Toronto Dominion Bank
TD
$204B
| $3.78M | ﹤0.01% |
64,566
-4,734
| -7% | -$266K |
|
1431
SPS Commerce
SPSC
$2.86B
| $3.75M | ﹤0.01% |
73,284
+124
| +0.2% | +$6.46K |
|
1432
Diodes
DIOD
$4.48B
| $3.72M | ﹤0.01% |
102,382
+117
| +0.1% | +$4.14K |
|
|
WRI
1433
DELISTED
Weingarten Realty Investors
WRI
| $3.72M | ﹤0.01% |
135,728
+119
| +0.1% | +$3.43K |
|
1434
American Financial Group
AFG
$12B
| $3.71M | ﹤0.01% |
36,160
+142
| +0.4% | +$14.3K |
|
1435
Hawaiian Electric Industries
HE
$2.06B
| $3.7M | ﹤0.01% |
84,928
+11
| +0% | +$461 |
|
1436
Autoliv
ALV
$8.85B
| $3.67M | ﹤0.01% |
52,082
+213
| +0.4% | +$15.6K |
|
|
CIT
1437
DELISTED
CIT Group Inc.
CIT
| $3.65M | ﹤0.01% |
69,399
-734
| -1% | -$37.1K |
|
|
CSLT
1438
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $3.64M | ﹤0.01% |
1,128,093
+671
| +0.1% | +$2.31K |
|
|
YARW
1439
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
| $3.58M | ﹤0.01% |
166
-1
| -0.6% | -$24.7K |
|
|
EV
1440
DELISTED
Eaton Vance Corp.
EV
| $3.58M | ﹤0.01% |
82,931
+22
| +0% | +$898 |
|
1441
Matthews International
MATW
$725M
| $3.5M | ﹤0.01% |
100,571
-8,940
| -8% | -$327K |
|
1442
CACI
CACI
$15B
| $3.5M | ﹤0.01% |
17,083
+581
| +4% | +$115K |
|
1443
NIO
NIO
$11.3B
| $3.44M | ﹤0.01% |
1,350,303
-272,695
| -17% | -$1.09M |
|
|
LSXMK
1444
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $3.42M | ﹤0.01% |
118,314
-1,249,034
| -91% | -$36.6M |
|
1445
Hilltop Holdings
HTH
$2.25B
| $3.42M | ﹤0.01% |
160,725
+524
| +0.3% | +$10.6K |
|
1446
Ingredion
INGR
$6.54B
| $3.41M | ﹤0.01% |
41,352
+2,448
| +6% | +$210K |
|
1447
Antero Resources
AR
$11.5B
| $3.4M | ﹤0.01% |
614,074
-1,072,966
| -64% | -$7.74M |
|
1448
Lindblad Expeditions
LIND
$2.24B
| $3.38M | ﹤0.01% |
188,531
+41
| +0% | +$673 |
|
|
GMS
1449
DELISTED
GMS Inc
GMS
| $3.37M | ﹤0.01% |
153,142
+100
| +0.1% | +$1.79K |
|
1450
Forte Biosciences
FBRX
$1.57B
| $3.35M | ﹤0.01% |
1,339
-341
| -20% | -$1.01M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.